108 related articles for article (PubMed ID: 34178697)
1. N6-Methylandenosine-Related lncRNAs in Tumor Microenvironment Are Potential Prognostic Biomarkers in Colon Cancer.
Zhang H; Zhao L; Li S; Wang J; Feng C; Li T; Du X
Front Oncol; 2021; 11():697949. PubMed ID: 34178697
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analysis of markers based on m6A related to prognosis combined with immune invasion of rectal adenocarcinoma.
Yan S; Zhang J; Li L; Chen G; Chen Z; Zhan W
Cancer Biomark; 2024; 40(1):95-109. PubMed ID: 38306025
[TBL] [Abstract][Full Text] [Related]
3. N6-Methylandenosine-Related lncRNA Signature Is a Novel Biomarkers of Prognosis and Immune Response in Colon Adenocarcinoma Patients.
Zhang P; Liu G; Lu L
Front Cell Dev Biol; 2021; 9():703629. PubMed ID: 34336856
[TBL] [Abstract][Full Text] [Related]
4. m6A-Related lncRNA to Develop Prognostic Signature and Predict the Immune Landscape in Bladder Cancer.
Li Z; Li Y; Zhong W; Huang P
J Oncol; 2021; 2021():7488188. PubMed ID: 34349798
[TBL] [Abstract][Full Text] [Related]
5. N6-Methyladenosine Related Long Non-Coding RNAs and Immune Cell Infiltration in the Tumor Microenvironment of Gastric Cancer.
Yu ZL; Zhu ZM
Biol Proced Online; 2021 Aug; 23(1):15. PubMed ID: 34332535
[TBL] [Abstract][Full Text] [Related]
6. N
Liu Z; Li S; Huang S; Wang T; Liu Z
Front Oncol; 2021; 11():704543. PubMed ID: 34395276
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of lncRNAs involved in m6A regulation for patients with ovarian cancer.
Zheng J; Guo J; Cao B; Zhou Y; Tong J
Cancer Cell Int; 2021 Jul; 21(1):363. PubMed ID: 34238292
[TBL] [Abstract][Full Text] [Related]
8. N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder Cancer.
Zhang Y; Zhu B; He M; Cai Y; Ying X; Jiang C; Ji W; Zeng J
Front Oncol; 2021; 11():710767. PubMed ID: 34458149
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
Yuan Q; Ren J; Li L; Li S; Xiang K; Shang D
Bioengineered; 2021 Dec; 12(1):2432-2448. PubMed ID: 34233576
[TBL] [Abstract][Full Text] [Related]
10. Identification of a robust signature for clinical outcomes and immunotherapy response in gastric cancer: based on N6-methyladenosine related long noncoding RNAs.
Han T; Xu D; Zhu J; Li J; Liu L; Deng Y
Cancer Cell Int; 2021 Aug; 21(1):432. PubMed ID: 34399770
[TBL] [Abstract][Full Text] [Related]
11. Immune Infiltrates of m
Feng ZY; Gao HY; Feng TD
Front Cell Dev Biol; 2021; 9():672248. PubMed ID: 34178999
[No Abstract] [Full Text] [Related]
12. Construction and Analysis of a Colorectal Cancer Prognostic Model Based on N6-Methyladenosine-Related lncRNAs.
Zeng H; Xu Y; Xu S; Jin L; Shen Y; Rajan KC; Bhandari A; Xia E
Front Cell Dev Biol; 2021; 9():698388. PubMed ID: 34490250
[TBL] [Abstract][Full Text] [Related]
13. N6-methylandenosine-related lncRNAs play an important role in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma.
Hu Y; Chen Y
Sci Rep; 2021 Sep; 11(1):17844. PubMed ID: 34497315
[TBL] [Abstract][Full Text] [Related]
14. Analysis of m6A-Related lncRNAs for Prognosis Value and Response to Immune Checkpoint Inhibitors Therapy in Hepatocellular Carcinoma.
Wang Y; Li N; Tian D; Zhou CW; Wang YH; Yang C; Zeng MS
Cancer Manag Res; 2021; 13():6451-6471. PubMed ID: 34429653
[TBL] [Abstract][Full Text] [Related]
15. Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma.
Wang L; Zhang S; Li H; Xu Y; Wu Q; Shen J; Li T; Xu Y
BMC Cancer; 2021 Jul; 21(1):876. PubMed ID: 34332578
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Analysis of the Immune-Oncology Targets and Immune Infiltrates of
Zhang X; Shen L; Cai R; Yu X; Yang J; Wu X; Zhu Y; Liu X
Front Cell Dev Biol; 2021; 9():686675. PubMed ID: 34277627
[TBL] [Abstract][Full Text] [Related]
17. The N
Zhao R; Li B; Zhang S; He Z; Pan Z; Guo Q; Qiu W; Qi Y; Zhao S; Wang S; Chen Z; Zhang P; Guo X; Xue H; Li G
Front Immunol; 2021; 12():653711. PubMed ID: 34354698
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma.
Qiu Y; Wang X; Fan Z; Zhan S; Jiang X; Huang J
Immun Inflamm Dis; 2021 Dec; 9(4):1596-1612. PubMed ID: 34432955
[TBL] [Abstract][Full Text] [Related]
19. Hub Long Noncoding RNAs with m6A Modification for Signatures and Prognostic Values in Kidney Renal Clear Cell Carcinoma.
Lin G; Wang H; Wu Y; Wang K; Li G
Front Mol Biosci; 2021; 8():682471. PubMed ID: 34295922
[No Abstract] [Full Text] [Related]
20. Integrated Analysis of the Immune Infiltrates and PD-L1 Expression of N6-Methyladenosine-Related Long Non-Coding RNAs in Colorectal Cancer.
Jiang Z; Zhang Y; Chen K; Yang X; Liu J
Int J Gen Med; 2021; 14():5017-5028. PubMed ID: 34511985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
